Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4151
Scully Royalty
SRL
$76.1M
| $249K | ﹤0.01% |
+29,100
| New | +$178K |
2025 Q4
0 quarters
|
|
|
INV
4152
Innventure Inc
INV
$42.6M
| $249K | ﹤0.01% |
+59,464
| New | +$250K |
2025 Q4
0 quarters
|
|
4153
SkinHealth Systems
SKIN
$82M
| $248K | ﹤0.01% |
178,287
+16,206
| +10% | +$23.4K |
2022 Q1
15 quarters
|
|
|
CLYM
4154
Climb Bio
CLYM
$628M
| $247K | ﹤0.01% |
61,853
+37,100
| +150% | +$89.1K |
2024 Q2
6 quarters
|
|
4155
DMC Global
BOOM
$119M
| $247K | ﹤0.01% |
36,964
+1,969
| +6% | +$13.6K |
2017 Q1
35 quarters
|
|
4156
Mistras Group
MG
$658M
| $247K | ﹤0.01% |
19,548
-3,660
| -16% | -$41.3K |
2016 Q3
37 quarters
|
|
4157
Hanover Bancorp
HNVR
$181M
| $247K | ﹤0.01% |
10,669
+1,769
| +20% | +$39.4K |
2024 Q3
5 quarters
|
|
|
HDRNW
4158
Hadron Energy Warrant
HDRNW
$2.8M
| $246K | ﹤0.01% |
+600,000
| New | +$411K |
2025 Q4
0 quarters
|
|
4159
Satellogic
SATL
$881M
| $245K | ﹤0.01% |
131,119
+33,882
| +35% | +$73.2K |
2025 Q2
2 quarters
|
|
|
SNBR
4160
DELISTED
Sleep Number
SNBR
| $245K | ﹤0.01% |
28,959
-1,169
| -4% | -$7.39K |
2013 Q2
50 quarters
|
|
4161
Dynagas LNG Partners
DLNG
$137M
| $244K | ﹤0.01% |
64,800
| – | – |
2020 Q2
22 quarters
|
|
|
LPRO
4162
DELISTED
Open Lending Corp
LPRO
| $244K | ﹤0.01% |
157,383
+12,963
| +9% | +$23K |
2022 Q1
15 quarters
|
|
|
NXDT
4163
NexPoint Diversified Real Estate Trust
NXDT
$281M
| $244K | ﹤0.01% |
63,639
+9,549
| +18% | +$31.3K |
2020 Q4
20 quarters
|
|
4164
ProFrac Holding
ACDC
$834M
| $243K | ﹤0.01% |
62,516
+45,198
| +261% | +$185K |
2022 Q3
13 quarters
|
|
4165
SKYX Platforms
SKYX
$160M
| $243K | ﹤0.01% |
111,909
+22,885
| +26% | +$40.8K |
2023 Q2
10 quarters
|
|
4166
ROBO Global Robotics & Automation Index ETF
ROBO
$2.08B
| $243K | ﹤0.01% |
3,500
| – | – |
2017 Q1
35 quarters
|
|
4167
Twin Disc
TWIN
$414M
| $241K | ﹤0.01% |
14,452
+12,227
| +550% | +$189K |
2023 Q3
9 quarters
|
|
|
AMBQ
4168
Ambiq Micro
AMBQ
$1.65B
| $241K | ﹤0.01% |
8,451
+1,883
| +29% | +$53.9K |
2025 Q3
1 quarter
|
|
4169
Landmark Bancorp
LARK
$191M
| $241K | ﹤0.01% |
9,196
+2,444
| +36% | +$64K |
2025 Q2
2 quarters
|
|
|
XYZ
4170
CALL
Block Inc
XYZ
$44.7B
| $241K | ﹤0.01% |
3,700
-130,900
| -97% | -$9.03M |
2023 Q4
8 quarters
|
|
4171
Under Armour Class C
UA
$1.97B
| $241K | ﹤0.01% |
50,120
-96,828
| -66% | -$431K |
2016 Q2
38 quarters
|
|
4172
Vista Gold
VGZ
$390M
| $236K | ﹤0.01% |
+120,000
| New | +$231K |
2025 Q4
0 quarters
|
|
4173
CALL
Aspen Aerogels
ASPN
$472M
| $236K | ﹤0.01% |
+83,400
| New | +$430K |
2025 Q4
0 quarters
|
|
4174
China Yuchai International
CYD
$1.2B
| $236K | ﹤0.01% |
6,646
-13,873
| -68% | -$506K |
2025 Q1
3 quarters
|
|
4175
Lifezone Metals
LZM
$346M
| $235K | ﹤0.01% |
55,097
+2,666
| +5% | +$12K |
2024 Q2
6 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.